Pfizer to Submit Data to FDA on Fourth Covid Shot Soon, CEO Says

Pfizer Inc. will soon submit data to U.S. regulators on a fourth dose of its Covid-19 vaccine, Chief Executive Officer Albert Bourla said.

Bourla said he spent Tuesday morning reviewing new data from various Covid vaccine studies, including one looking at the effects of a fourth dose of the currently available vaccine, as well as a new formulation that will protect against multiple coronavirus variants.

“They look encouraging,” Bourla said in an interview on Bloomberg Television’s “Balance of Power With David Westin,” noting that Pfizer still needs to collect more information.

WATCH: Pfizer Chairman and CEO Albert Bourla discusses his new book “Moonshot,” and progress on developing a fourth Covid-19 booster.

Source: Bloomberg

Pandemic concerns are abating as the omicron surge ...